Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
iShares Biotechnology ETF
IBB
$9.81B
| $6.33M | ﹤0.01% |
50,000
+29,400
| +143% | +$3.61M |
|
|
TGI
1902
DELISTED
Triumph Group
TGI
| $6.31M | ﹤0.01% |
244,944
-95,077
| -28% | -$2.42M |
|
1903
RenaissanceRe
RNR
$13.2B
| $6.31M | ﹤0.01% |
25,962
+1,468
| +6% | +$356K |
|
1904
NNN REIT
NNN
$8.71B
| $6.3M | ﹤0.01% |
145,987
+10,468
| +8% | +$435K |
|
1905
Cheesecake Factory
CAKE
$5.63B
| $6.3M | ﹤0.01% |
100,600
+23,533
| +31% | +$1.25M |
|
1906
Trip.com Group
TCOM
$29.1B
| $6.29M | ﹤0.01% |
107,301
-38,647
| -26% | -$2.32M |
|
1907
MYR Group
MYRG
$5.14B
| $6.29M | ﹤0.01% |
34,660
+11,055
| +47% | +$1.62M |
|
1908
PUT
Kenvue
KVUE
$36.6B
| $6.28M | ﹤0.01% |
+300,000
| New | +$6.82M |
|
1909
Cadiz
CDZI
$299M
| $6.27M | ﹤0.01% |
2,096,871
+1,051,140
| +101% | +$3.02M |
|
1910
Applied Optoelectronics
AAOI
$11.4B
| $6.27M | ﹤0.01% |
243,994
+114,870
| +89% | +$1.86M |
|
1911
OceanFirst Financial
OCFC
$1.84B
| $6.27M | ﹤0.01% |
355,886
+16,804
| +5% | +$280K |
|
1912
National Health Investors
NHI
$3.44B
| $6.26M | ﹤0.01% |
89,341
+28,969
| +48% | +$2.12M |
|
1913
PUT
VanEck Oil Services ETF
OIH
$1.97B
| $6.26M | ﹤0.01% |
27,200
-115,000
| -81% | -$25.8M |
|
1914
California Water Service
CWT
$3.09B
| $6.25M | ﹤0.01% |
137,511
+28,416
| +26% | +$1.36M |
|
1915
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $6.25M | ﹤0.01% |
+129,920
| New | +$6.21M |
|
1916
Kymera Therapeutics
KYMR
$9.11B
| $6.25M | ﹤0.01% |
143,181
+57,969
| +68% | +$2M |
|
1917
Redwire
RDW
$3.38B
| $6.25M | ﹤0.01% |
383,289
+216,084
| +129% | +$2.82M |
|
1918
Patrick Industries
PATK
$2.81B
| $6.23M | ﹤0.01% |
67,519
+15,345
| +29% | +$1.3M |
|
1919
Madison Square Garden
MSGE
$3.75B
| $6.23M | ﹤0.01% |
155,848
+107,589
| +223% | +$3.8M |
|
1920
Acadia Realty Trust
AKR
$2.83B
| $6.21M | ﹤0.01% |
334,541
-118,941
| -26% | -$2.3M |
|
1921
Grand Canyon Education
LOPE
$3.76B
| $6.21M | ﹤0.01% |
32,860
+13,888
| +73% | +$2.57M |
|
1922
Surgery Partners
SGRY
$1.96B
| $6.21M | ﹤0.01% |
279,246
+186,377
| +201% | +$4.14M |
|
1923
Genworth Financial
GNW
$3.7B
| $6.2M | ﹤0.01% |
796,966
+252,326
| +46% | +$1.76M |
|
1924
MSC Industrial Direct
MSM
$6.7B
| $6.18M | ﹤0.01% |
72,721
+37,140
| +104% | +$2.93M |
|
1925
Independent Bank
INDB
$4.02B
| $6.17M | ﹤0.01% |
98,190
+30,677
| +45% | +$1.86M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.